Evidence map›Paper›PMID 24381245›Full record

ArticleeLife2013

Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy.

Svasti Haricharan, Jie Dong, Sarah Hein, Jay P Reddy, Zhijun Du, Michael Toneff, Kimberly Holloway, Susan G Hilsenbeck, Shixia Huang, Rachel Atkinson and 9 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 58 citations in OpenAlex.

  1. STAT3 Inhibition to Treat Ulcerative Colitis-Associated Colorectal Cancer.International journal of molecular sciences · 2025
    Article
  2. Rat Models of Breast Cancer.Advances in experimental medicine and biology · 2025
    Review
  3. Models for Studying Ductal Carcinoma In Situ Progression.Advances in experimental medicine and biology · 2025
    Review
  4. Article
  5. Advances in Immunocompetent Mouse and Rat Models.Cold Spring Harbor perspectives in medicine · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Short-term PI3K Inhibition Prevents Breast Cancer in Preclinical Models.Cancer prevention research (Philadelphia, Pa.) · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer.Cancer prevention research (Philadelphia, Pa.) · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 1 country.

Svasti HaricharanDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, United States.
Jie Dong
Sarah Hein
Jay P Reddy
Zhijun Du
Michael Toneff
Kimberly Holloway
Susan G Hilsenbeck
Shixia Huang
Rachel Atkinson
Wendy Woodward
Sonali Jindal
Virginia F Borges
Carolina Gutierrez
Hong Zhang
Pepper J Schedin
C Kent Osborne
David J Tweardy
Yi Li
Baylor College of Medicine · USThe University of Texas MD Anderson Cancer Center · USUniversity of Colorado Denver · USUniversity of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
TUMOR SUPPRESSOR GENES IN BREAST CANCER DEVELOPMENTP50CA058183 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI OSBORNE, C KENT · 1992 to 2012
$30.9M
The Core of the Computational BiologyU54CA149196 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI WONG, STEPHEN TC · 2010 to 2015
$10.6M
NSAIDs During Postpartum Involution for Breast Cancer ChemopreventionR01CA169175 · NCI · UNIVERSITY OF COLORADO DENVER · PI SCHEDIN, PEPPER J · 2013 to 2024
$4.8M
CELL &MOLECULAR BIOLOGY OF AGINGT32AG000183 · NIA · BAYLOR COLLEGE OF MEDICINE · PI DONEHOWER, LAWRENCE A. · 1989 to 2015
$3.7M
Oncogene susceptibility: physiological state & breast cell differentiationR01CA124820 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LI, YI · 2010 to 2014
$1.5M
PROGENITOR CELLS AND ONCOGENE TARGETS IN BREAST CANCERR01CA113869 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LI, YI · 2005 to 2009
$1.4M
Stat3 Probes that Target Breast Cancer Stem CellsR21CA149783 · NCI · BAYLOR COLLEGE OF MEDICINE · PI TWEARDY, DAVID JOHN · 2010 to 2011
$362k
NCI NIH HHS CA113869NCI NIH HHS CA124820NCI NIH HHS P30 CA046934NCI NIH HHS P30 CA125123NCI NIH HHS P50 CA058183NCI NIH HHS R01 CA113869NCI NIH HHS R01 CA124820NCI NIH HHS R01 CA169175NCI NIH HHS R21 CA149783NCI NIH HHS U54 CA149196NCI NIH HHS U54CA149196NIA NIH HHS T32 AG000183
6 · The paper itself

Abstract

While a first pregnancy before age 22 lowers breast cancer risk, a pregnancy after age 35 significantly increases life-long breast cancer risk. Pregnancy causes several changes to the normal breast that raise barriers to transformation, but how pregnancy can also increase cancer risk remains unclear. We show in mice that pregnancy has different effects on the few early lesions that have already developed in the otherwise normal breast-it causes apoptosis evasion and accelerated progression to cancer. The apoptosis evasion is due to the normally tightly controlled STAT5 signaling going astray-these precancerous cells activate STAT5 in response to pregnancy/lactation hormones and maintain STAT5 activation even during involution, thus preventing the apoptosis normally initiated by oncoprotein and involution. Short-term anti-STAT5 treatment of lactation-completed mice bearing early lesions eliminates the increased risk after a pregnancy. This chemoprevention strategy has important implications for preventing increased human breast cancer risk caused by pregnancy. DOI: http://dx.doi.org/10.7554/eLife.00996.001.

Indexed as

Disease Models, AnimalAnimalsApoptosisBreast NeoplasmsCarcinogenesisCell DivisionFemaleMiceMutationOncogenesPregnancyPregnancy Complications, NeoplasticSTAT5 Transcription FactorSTAT5 Transcription Factorbreast cancerchemopreventionpregnancySTAT5

Identifiers

PMID24381245
PMCPMC3874103
OpenAlexW2162753998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.